AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26026604 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) treatment
Number of subjects: 78
Study 25682570 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor bicycle exercise program for twelve weeks
Number of subjects: 33
Study 24338461 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic debridement
Number of subjects: 120
Study 24338461 — intervention group
Group type: COMPARATOR
Intervention: Intraarticular steroid injection
Number of subjects: 120
Study 20538138 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of Lp(a) distribution (>/=32.9 mg/dl)
Number of subjects: 1002
Study 20538138 — intervention group
Group type: COMPARATOR
Intervention: Lowest quartile of Lp(a) distribution (<32.9 mg/dl)
Number of subjects: 1002
Study 18261061 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 93
Study 18261061 — intervention group
Group type: COMPARATOR
Intervention: Headbox oxygen
Number of subjects: 93
Study 18261061 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 93
Study 16368299 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato extract, 250 mg Lyc-O-Mato, during an 8-week treatment period
Number of subjects: 31
Study 16368299 — intervention group
Group type: COMPARATOR
Intervention: Placebo during the 4-week placebo period
Number of subjects: 31
Study 15018673 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming personal self-standards in Experiment I
Number of subjects: 2
Study 15018673 — intervention group
Group type: COMPARATOR
Intervention: Priming no standards or normative self-standards in Experiment I
Number of subjects: 2
Study 15018673 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming personal self-standards in Experiment II
Number of subjects: 2
Study 10893359 — intervention group
Group type: EXPERIMENTAL
Intervention: Added dead space during exercise
Number of subjects: 7
Study 10893359 — intervention group
Group type: COMPARATOR
Intervention: Control exercise (without added dead space)
Number of subjects: 7
Study 9368236 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (200 mg/day for 6 months)
Number of subjects: 50
Study 9368236 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment without magnesium supplementation (control group)
Number of subjects: 50
Study 1544017 — intervention group
Group type: EXPERIMENTAL
Intervention: One dose of antidepressant medication at night
Number of subjects: 89
Study 1544017 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of medication during the day
Number of subjects: 89
Study 1544017 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-chosen regime (either A or B)
Number of subjects: 89
Study 1544017 — intervention group
Group type: COMPARATOR
Intervention: All regimes (once-a-day and three-times-a-day)
Number of subjects: 89
Study 3929553 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose fentanyl (50 micrograms/kg)
Number of subjects: 32
Study 3929553 — intervention group
Group type: COMPARATOR
Intervention: Halothane anesthesia
Number of subjects: 32
Study 31790604 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg)
Number of subjects: 14
Study 31790604 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 30326883 — intervention group
Group type: EXPERIMENTAL
Intervention: iMOVE therapy
Number of subjects: 42
Study 30326883 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 42
Study 27721227 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal oxygen supplementation (2 L/min to 3 L/min) with standard hydration (n = 176)
Number of subjects: 348
Study 27721227 — intervention group
Group type: COMPARATOR
Intervention: Standard hydration alone (control group) (n = 176)
Number of subjects: 348
Study 25467955 — intervention group
Group type: EXPERIMENTAL
Intervention: Wedged insole intervention to reduce peak external knee adduction moments (KAMs)
Number of subjects: 46
Study 25467955 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group with no intervention
Number of subjects: 46
Study 22849536 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet orange essential oil (2.5 drops)
Number of subjects: 40
Study 22849536 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet orange essential oil (10 drops)
Number of subjects: 40
Study 22849536 — intervention group
Group type: COMPARATOR
Intervention: Tea tree essential oil (control aroma: 2.5 drops)
Number of subjects: 40
Study 22849536 — intervention group
Group type: COMPARATOR
Intervention: Water (nonaromatic control: 2.5 drops)
Number of subjects: 40
Study 20105676 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinyl Polysiloxane (VPS) with full-arch tray
Number of subjects: 50
Study 20105676 — intervention group
Group type: COMPARATOR
Intervention: Polyether (PE) with full-arch tray
Number of subjects: 50
Study 20105676 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinyl Polysiloxane (VPS) with dual-arch tray
Number of subjects: 50
Study 20105676 — intervention group
Group type: COMPARATOR
Intervention: Polyether (PE) with dual-arch tray
Number of subjects: 50
Study 18325675 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented Reality (AR) as an adjunct to analgesia and sedation
Number of subjects: 42
Study 18325675 — intervention group
Group type: COMPARATOR
Intervention: Basic cognitive therapy (Control)
Number of subjects: 42
Study 18325675 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented Reality (AR)
Number of subjects: 42
Study 16146625 — intervention group
Group type: EXPERIMENTAL
Intervention: Genesis Total Knee Arthroplasty System (cemented components)
Number of subjects: 74
Study 16146625 — intervention group
Group type: EXPERIMENTAL
Intervention: Genesis Total Knee Arthroplasty System (cementless components)
Number of subjects: 74
Study 16146625 — intervention group
Group type: EXPERIMENTAL
Intervention: Genesis Total Knee Arthroplasty System
Number of subjects: 74
Study 12925455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 943
Study 12925455 — intervention group
Group type: COMPARATOR
Intervention: Pexelizumab 2.0 mg/kg bolus
Number of subjects: 943
Study 12925455 — intervention group
Group type: COMPARATOR
Intervention: Pexelizumab 2.0 mg/kg bolus plus 0.05 mg/kg per h for 20 hours
Number of subjects: 943
Study 10800064 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoral (cyclosporin A) at twice the last i.v. dose
Number of subjects: 14
Study 10800064 — intervention group
Group type: COMPARATOR
Intervention: Neoral (cyclosporin A) at the same last i.v. dose
Number of subjects: 14
Study 8717398 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid vaccine combining outer membrane protein F (OprF) and outer membrane protein I (OprI)
Number of subjects: 90
Study 8717398 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunization with recombinant OprI expressing Salmonella dublin
Number of subjects: 90
Study 8717398 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant OprI immunization in human volunteers
Number of subjects: 90
Study 1449918 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 12.5 mg three times daily for 28 days
Number of subjects: 105
Study 1449918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 1449918 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate 20 mg three times daily for 28 days
Number of subjects: 105
Study 6727272 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of 20 mg diltiazem hydrochloride
Number of subjects: 6
Study 6727272 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 120 mg diltiazem in solution form
Number of subjects: 6
Study 6727272 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 120 mg diltiazem as two 60-mg sustained-release tablets
Number of subjects: 6
Study 29248897 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial warnings
Number of subjects: 2149
Study 28283202 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational course on VAP prevention guidelines
Number of subjects: 105
Study 28283202 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 105
Study 26897923 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.40 USD for each of four visits
Number of subjects: 23
Study 26897923 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cash)
Number of subjects: 23
Study 26897923 — intervention group
Group type: EXPERIMENTAL
Intervention: More antenatal visits
Number of subjects: 23
Study 26897923 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.20 USD for each of four visits
Number of subjects: 23
Study 26897923 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.40 USD for a single first trimester visit only
Number of subjects: 23
Study 23340983 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA) at 20-22 °C (GA I)
Number of subjects: 90
Study 23340983 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA) at 23-25 °C (GA II)
Number of subjects: 90
Study 23340983 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural Anesthesia (EA) at 20-22 °C (EA I)
Number of subjects: 90
Study 23340983 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural Anesthesia (EA) at 23-25 °C (EA II)
Number of subjects: 90
Study 23340983 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral-Sciatic Block (FS) at 20-22 °C (FS I)
Number of subjects: 90
Study 23340983 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral-Sciatic Block (FS) at 23-25 °C (FS II)
Number of subjects: 90
Study 21975350 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral letrozole (2.5 mg/day)
Number of subjects: 250
Study 21975350 — intervention group
Group type: COMPARATOR
Intervention: Oral exemestane (25 mg/day)
Number of subjects: 250
Study 18304286 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg taken on demand for up to 12 weeks
Number of subjects: 188
Study 17000812 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard combined spinal epidural (Std CSE) with hyperbaric bupivacaine 10 mg and intrathecal fentanyl 15 microg
Number of subjects: 40
Study 17000812 — intervention group
Group type: COMPARATOR
Intervention: Sequential combined spinal epidural (Seq CSE) with hyperbaric bupivacaine 5 mg and intrathecal fentanyl 15 microg
Number of subjects: 40
Study 14580657 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 24
Study 14580657 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 24
Study 10962915 — intervention group
Group type: EXPERIMENTAL
Intervention: DMARD + prednisolone
Number of subjects: 26
Study 10962915 — intervention group
Group type: COMPARATOR
Intervention: DMARD alone
Number of subjects: 26
Study 10962915 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 26
Study 8981127 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine oviductal epithelial cell co-culture
Number of subjects: 219
Study 8981127 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted hatching by zona drilling
Number of subjects: 219
Study 8981127 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted hatching by zona drilling in patients aged > or = 35 years
Number of subjects: 219
Study 1451523 — intervention group
Group type: EXPERIMENTAL
Intervention: Brand new condom lot
Number of subjects: 262
Study 1451523 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom lot aged 81 months
Number of subjects: 262
Study 1451523 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical predictor models using ultimate elongation, Condom Quality Index, and percent of condoms failing the airburst volume test
Number of subjects: 262
Study 1451523 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of the condom lot
Number of subjects: 262
Study 6691877 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam-fentanyl-nitrous oxide
Number of subjects: 100
Study 6691877 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone-fentanyl-nitrous oxide
Number of subjects: 100
Study 30698339 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Support Group (ESG)
Number of subjects: 71
Study 30698339 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Support Group (SSG)
Number of subjects: 71
Study 30698339 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 71
Study 29127848 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 800mg QD
Number of subjects: 1447
Study 29127848 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 400mg QD
Number of subjects: 1447
Study 29127848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1447
Study 29127848 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 800mg QD and 1200mg QD
Number of subjects: 1447
Study 25670917 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (2 μg.kg(‐1) bolus, 2‐7 μg.kg(‐1).min(‐1) infusion)
Number of subjects: 62
Study 25670917 — intervention group
Group type: COMPARATOR
Intervention: High-dose sufentanil-sevoflurane (control group)
Number of subjects: 62
Study 25119853 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cholesterol supplementation (9 g kg(‐1)) with rapeseed meal (RSM)
Number of subjects: 0
Study 25119853 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cholesterol supplementation (9 g kg(‐1)) with cottonseed meal (CSM)
Number of subjects: 0
Study 22879096 — intervention group
Group type: EXPERIMENTAL
Intervention: Priority level 1 intervention group (immediate call of an ambulance)
Number of subjects: 942
Study 22879096 — intervention group
Group type: COMPARATOR
Intervention: Standard priority level 2 control group (within 30 minutes)
Number of subjects: 942
Study 19262229 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil (15 mg/day)
Number of subjects: 136
Study 19262229 — intervention group
Group type: COMPARATOR
Intervention: Isosorbide dinitrate (30 mg/day)
Number of subjects: 136
Study 19262229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 17852947 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily administration of amphotericin B deoxycholate (1 mg/kg)
Number of subjects: 28
Study 17852947 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate-day administration of amphotericin B deoxycholate (2 mg/kg)
Number of subjects: 28
Study 17852947 — intervention group
Group type: COMPARATOR
Intervention: Both groups (OD and AD)
Number of subjects: 28
Study 15377681 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of the subthalamic nucleus (STN)
Number of subjects: 10
Study 11576953 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 1715
Study 11576953 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 1715
Study 11576953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1715
Study 11576953 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan or Amlodipine
Number of subjects: 1715
Study 9522109 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone 2000 mg daily
Number of subjects: 111
Study 9522109 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 8829021 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide 2% TID + Timolol 0.5% BID
Number of subjects: 97
Study 8829021 — intervention group
Group type: COMPARATOR
Intervention: Betaxolol 0.5% BID
Number of subjects: 97
Study 8829021 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.5% BID
Number of subjects: 97
Study 2390432 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox 250 mg three times daily and cholestyramine 4 g three times daily
Number of subjects: 28
Study 2390432 — intervention group
Group type: COMPARATOR
Intervention: Cholestyramine alone
Number of subjects: 28
Study 2390432 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox added to cholestyramine therapy
Number of subjects: 28
Study 7409937 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of diazepam
Number of subjects: 75
Study 7409937 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg of pentobarbital
Number of subjects: 75
Study 7409937 — intervention group
Group type: EXPERIMENTAL
Intervention: pentobarbital
Number of subjects: 75
Study 7409937 — intervention group
Group type: EXPERIMENTAL
Intervention: diazepam
Number of subjects: 75
Study 30650260 — intervention group
Group type: EXPERIMENTAL
Intervention: ELX-02 (0.3 mg/kg to 7.5 mg/kg)
Number of subjects: 0
Study 27254291 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced cookstove intervention
Number of subjects: 4
Study 27254291 — intervention group
Group type: EXPERIMENTAL
Intervention: Photovoice methodology
Number of subjects: 4
Study 23592830 — intervention group
Group type: EXPERIMENTAL
Intervention: EFV (600 mg) on-RIF
Number of subjects: 780
Study 23592830 — intervention group
Group type: COMPARATOR
Intervention: EFV (600 mg) off-RIF
Number of subjects: 780
Study 23592830 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight ≥60 kg on-RIF
Number of subjects: 780
Study 21991729 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 microg/kg bolus followed by 0.4 microg/kg/hr infusion)
Number of subjects: 40
Study 21991729 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 40
Study 18940191 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum omega-3 fatty acids (ALA, EPA, DHA)
Number of subjects: 60
Study 18940191 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum omega-3/omega-6 ratio
Number of subjects: 60
Study 17078771 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting therapy (FT) consisting of 10 days of starvation followed by 5 days of refeeding
Number of subjects: 58
Study 17078771 — intervention group
Group type: COMPARATOR
Intervention: Control therapy (basic treatment consisting of pharmacotherapy and brief psychotherapy)
Number of subjects: 58
Study 15641874 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 113
Study 11231867 — intervention group
Group type: EXPERIMENTAL
Intervention: Echinaforce (Echinacea purpurea) for 6 months
Number of subjects: 50
Study 11231867 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 50
Study 9080920 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 2382
Study 9080920 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium reduction intervention
Number of subjects: 2382
Study 9080920 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined weight loss and sodium reduction intervention
Number of subjects: 2382
Study 9080920 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2382
Study 8403071 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuelin liquid (NSRT)
Number of subjects: 16
Study 8403071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 3949238 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 9
Study 3949238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 3949238 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine
Number of subjects: 9
Study 3949238 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 9
Study 31906748 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (MT) - a single individualized session along with a recorder and journal for home use
Number of subjects: 173
Study 31906748 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Plus - weekly group MT sessions along with a recorder and journal for home use
Number of subjects: 173
Study 31906748 — intervention group
Group type: COMPARATOR
Intervention: Control - standard of care
Number of subjects: 173
Study 30919549 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker-guided treatment strategy
Number of subjects: 894
Study 30919549 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 894
Study 28654556 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 100 μg + dexmedetomidine 200 μg + normal saline 100 mL (group D)
Number of subjects: 210
Study 28654556 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil 100 μg + normal saline 100 mL (group C)
Number of subjects: 210
Study 26910198 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted conditions
Number of subjects: 3387
Study 26910198 — intervention group
Group type: EXPERIMENTAL
Intervention: Nontargeted conditions
Number of subjects: 3387
Study 26910198 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation units for targeted conditions
Number of subjects: 3387
Study 26910198 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation units for nontargeted conditions
Number of subjects: 3387
Study 26910198 — intervention group
Group type: COMPARATOR
Intervention: Changes in observation-unit stays
Number of subjects: 3387
Study 25526455 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy for older patients with stage II disease
Number of subjects: 1021
Study 25526455 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy for older patients with stage III disease
Number of subjects: 1021
Study 25526455 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy for older patients with colon cancer
Number of subjects: 1021
Study 25526455 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy for older patients with rectal cancer
Number of subjects: 1021
Study 25526455 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative short-course radiotherapy for older patients with stage III rectal cancer
Number of subjects: 1021
Study 25526455 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative short-course radiotherapy for older patients with rectal cancer
Number of subjects: 1021
Study 25526455 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for older patients with colorectal cancer
Number of subjects: 1021
Study 25526455 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for rectal cancer patients aged ≥80 years
Number of subjects: 1021
Study 21972424 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20mg daily for three months
Number of subjects: 40
Study 21972424 — intervention group
Group type: COMPARATOR
Intervention: Placebo for three months
Number of subjects: 40